More than just immune evasion: Hijacking complement by Plasmodium falciparum

Molecular Immunology

Volumn 67, Issue 1, 2015, Pages 71-84

  Schmidt, Christoph Q ^a   Kennedy, Alexander T ^b   Tham, Wai Hong ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Complement; Complement receptor 1; Evasion strategies; Parasite invasion; Plasmodium falciparum; Severe malaria pathogenesis

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT FACTOR H; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT FACTOR H, HUMAN; COMPLEMENT FACTOR I; COMPLEMENT RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; BRAIN MALARIA; CLINICAL TRIAL (TOPIC); COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DNA POLYMORPHISM; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNITY; MALARIA; MEROZOITE; NONHUMAN; PARASITE SURVIVAL; PATHOGEN CLEARANCE; PATHOGENESIS; PLACENTA MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; CHEMISTRY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LIFE CYCLE STAGE; MALARIA FALCIPARUM; PARASITOLOGY; PATHOLOGY;

PLASMODIUM FALCIPARUM;

ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; GENE EXPRESSION; HUMANS; IMMUNE EVASION; LIFE CYCLE STAGES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT;

EID: 84936985803     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.03.006     Document Type: Review

References (141)

1. Adam C., Géniteau M., Gougerot-Pocidalo M., Verroust P., Lebras J., Gibert C., Morel-Maroger L. Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect. Immun. 1981, 31:530-535.
2. Adams J.H., Sim B.K., Dolan S.A., Fang X., Kaslow D.C., Miller L.H. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:7085-7089.
3. Amara U., Flierl M.A., Rittirsch D., Klos A., Chen H., Acker B., Bruckner U.B., Nilsson B., Gebhard F., Lambris J.D., et al. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 2010, 185:5628-5636.
4. Awandare G.A., Spadafora C., Moch J.K., Dutta S., Haynes J.D., Stoute J.A. Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes. Mol. Biochem. Parasitol. 2011, 177:57-60.
5. Baum J., Richard D., Healer J., Rug M., Krnajski Z., Gilberger T.-W., Green J.L., Holder A.A., Cowman A.F. A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites. J. Biol. Chem. 2006, 281:5197-5208.
6. Baum J., Chen L., Healer J., Lopaticki S., Boyle M., Triglia T., Ehlgen F., Ralph S.A., Beeson J.G., Cowman A.F. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 2009, 39:371-380.
7. Baxter R.H.G., Steinert S., Chelliah Y., Volohonsky G., Levashina E.A., Deisenhofer J. A heterodimeric complex of the LRR proteins LRIM1 and APL1C regulates complement-like immunity in Anopheles gambiae. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16817-16822.
8. Bellamy R., Kwiatkowski D., Hill A.V. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:312-316.
9. Bernet J., Mullick J., Singh A.K., Sahu A. Viral mimicry of the complement system. J. Biosci. 2003, 28:249-264.
10. Birmingham D.J., Hebert L.A. CR1 and CR1-like: the primate immune adherence receptors. Immunol. Rev. 2001, 180:100-111.
11. Blandin S., Shiao S.-H., Moita L.F., Janse C.J., Waters A.P., Kafatos F.C., Levashina E.A. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell 2004, 116:661-670.
12. Blaum B.S., Hannan J.P., Herbert A.P., Kavanagh D., Uhrín D., Stehle T. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat. Chem. Biol. 2015, 11:77-82.
13. Butcher G.A., Mitchell G.H., Cohen S. Letter: mechanism of host specificity in malarial infection. Nature 1973, 244:40-41.
14. Charnock-Jones D.S., Burton G.J. Placental vascular morphogenesis. Baillièreaposs Best Pract. Amp Res. Clin. Obstet. Amp. Gynaecol. 2000, 14:953-968.
15. Chen Q., Heddini A., Barragan A., Fernandez V., Pearce S.F., Wahlgren M. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 2000, 192:1-10.
16. Clark S.J., Perveen R., Hakobyan S., Morgan B.P., Sim R.B., Bishop P.N., Day A.J. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J. Biol. Chem. 2010, 285:30192-30202.
17. Cockburn I.A., Mackinnon M.J., O'Donnell A., Allen S.J., Moulds J.M., Baisor M., Bockarie M., Reeder J.C., Rowe J.A. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:272-277.
18. Conroy A., Serghides L., Finney C., Owino S.O., Kumar S., Gowda D.C., Liles W.C., Moore J.M., Kain K.C. C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. PLoS ONE 2009, 4:e4953.
19. Conroy A.L., McDonald C.R., Silver K.L., Liles W.C., Kain K.C. Complement activation: a critical mediator of adverse fetal outcomes in placental malaria?. Trends Parasitol. 2011, 27:294-299.
20. Conroy A.L., Silver K.L., Zhong K., Rennie M., Ward P., Sarma J.V., Molyneux M.E., Sled J., Fletcher J.F., Rogerson S., et al. Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Amp. Microbe 2013, 13:215-226.
21. Covas D.T., de Oliveira F.S., Rodrigues E.S., Abe-Sandes K., Silva W.A., Fontes A.M. Knops blood group haplotypes among distinct Brazilian populations. Transfusion (Paris) 2007, 47:147-153.
22. Crosnier C., Bustamante L.Y., Bartholdson S.J., Bei A.K., Theron M., Uchikawa M., Mboup S., Ndir O., Kwiatkowski D.P., Duraisingh M.T., et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011, 480:534-537.
23. Darley M.M., Ramos T.N., Wetsel R.A., Barnum S.R. Deletion of carboxypeptidase N delays onset of experimental cerebral malaria. Parasite Immunol. 2012, 34:444-447.
24. Dasari P., Reiss K., Lingelbach K., Baumeister S., Lucius R., Udomsangpetch R., Bhakdi S.C., Bhakdi S. Digestive vacuoles of Plasmodium falciparum are selectively phagocytosed by and impair killing function of polymorphonuclear leukocytes. Blood 2011, 118:4946-4956.
25. Dasari P., Heber S.D., Beisele M., Torzewski M., Reifenberg K., Orning C., Fries A., Zapf A.-L., Baumeister S., Lingelbach K., et al. Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation. Blood 2012, 119:4301-4310.
26. Dasari P., Fries A., Heber S.D., Salama A., Blau I.-W., Lingelbach K., Bhakdi S.C., Udomsangpetch R., Torzewski M., Reiss K., et al. Malarial anemia: digestive vacuole of Plasmodium falciparum mediates complement deposition on bystander cells to provoke hemophagocytosis. Med. Microbiol. Immunol. (Berl.) 2014, 203:383-393.
27. Datta P.K., Rappaport J. HIV and complement: hijacking an immune defense. Biomed. Pharmacother. Biomed. Pharmacother. 2006, 60:561-568.
28. Dunk C., Shams M., Nijjar S., Rhaman M., Qiu Y., Bussolati B., Ahmed A. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am. J. Pathol. 2000, 156:2185-2199.
29. Dunkelberger J.R., Song W.-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010, 20:34-50.
30. Duraisingh M.T., Triglia T., Ralph S.A., Rayner J.C., Barnwell J.W., McFadden G.I., Cowman A.F. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 2003, 22:1047-1057.
31. Dykman T.R., Hatch J.A., Atkinson J.P. Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J. Exp. Med. 1984, 159:691-703.
32. Fearon D.T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 1980, 152:20-30.
33. Ferreira V.P., Herbert A.P., Hocking H.G., Barlow P.N., Pangburn M.K. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 2006, 177:6308-6316.
34. Fowkes F.J.I., Michon P., Pilling L., Ripley R.M., Tavul L., Imrie H.J., Woods C.M., Mgone C.S., Luty A.J.F., Day K.P. Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea. Malar. J. 2008, 7:1.
35. Fraiture M., Baxter R.H.G., Steinert S., Chelliah Y., Frolet C., Quispe-Tintaya W., Hoffmann J.A., Blandin S.A., Levashina E.A. Two mosquito LRR proteins function as complement control factors in the TEP1-mediated killing of Plasmodium. Cell Host Amp. Microbe 2009, 5:273-284.
36. Frolet C., Thoma M., Blandin S., Hoffmann J.A., Levashina E.A. Boosting NF-kappaB-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei. Immunity 2006, 25:677-685.
37. Gandhi M., Singh A., Dev V., Adak T., Dashd A.P., Joshi H. Role of CR1 Knops polymorphism in the pathophysiology of malaria: Indian scenario. J. Vector Borne Dis. 2009, 46:288-294.
38. Geva E., Ginzinger D.G., Zaloudek C.J., Moore D.H., Byrne A., Jaffe R.B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J. Clin. Endocrinol. Metab. 2002, 87:4213-4224.
39. Gilberger T.-W., Thompson J.K., Triglia T., Good R.T., Duraisingh M.T., Cowman A.F. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J. Biol. Chem. 2003, 278:14480-14486.
40. Gratzer W.B., Dluzewski A.R. The red blood cell and malaria parasite invasion. Semin. Hematol. 1993, 30:232-247.
41. Hayton K., Gaur D., Liu A., Takahashi J., Henschen B., Singh S., Lambert L., Furuya T., Bouttenot R., Doll M., et al. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 2008, 4:40-51.
42. Herrera A.H., Xiang L., Martin S.G., Lewis J., Wilson J.G. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin. Immunol. Immunopathol. 1998, 87:176-183.
43. Holers V.M., Chaplin D.D., Leykam J.F., Gruner B.A., Kumar V., Atkinson J.P. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:2459-2463.
44. Holmberg V., Onkamo P., Lahtela E., Lahermo P., Bedu-Addo G., Mockenhaupt F.P., Meri S. Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria. Malar. J. 2012, 11:61.
45. Jacob A., Hack B., Chiang E., Garcia J.G.N., Quigg R.J., Alexander J.J. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2010, 24:1682-1688.
46. Jacob A., Hack B., Chen P., Quigg R.J., Alexander J.J. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB. J. Neurochem. 2011, 119:1041-1051.
47. Jallow M., Teo Y.Y., Small K.S., Rockett K.A., Deloukas P., Clark T.G., Kivinen K., Bojang K.A., Conway D.J., Pinder M., et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 2009, 41:657-665.
48. Kaneko O., Mu J., Tsuboi T., Su X., Torii M. Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol. Biochem. Parasitol. 2002, 121:275-278.
49. Kaul D.K., Roth E.F., Nagel R.L., Howard R.J., Handunnetti S.M. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood 1991, 78:812-819.
50. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
51. Khattab A., Kremsner P.G., Meri S. Complement activation in primiparous women from a malaria endemic area is associated with reduced birthweight. Placenta 2013, 34:162-167.
52. Kim H., Erdman L.K., Lu Z., Serghides L., Zhong K., Dhabangi A., Musoke C., Gerard C., Cserti-Gazdewich C., Liles W.C., et al. Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria. Infect. Immun. 2014, 82:371-379.
53. Kirkitadze M.D., Barlow P.N. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 2001, 180:146-161.
54. Klickstein L.B., Bartow T.J., Miletic V., Rabson L.D., Smith J.A., Fearon D.T. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 1988, 168:1699-1717.
55. Kosoy R., Ransom M., Chen H., Marconi M., Macciardi F., Glorioso N., Gregersen P.K., Cusi D., Seldin M.F. Evidence for malaria selection of a CR1 haplotype in Sardinia. Genes Immun. 2011, 12:582-588.
56. Krych M., Hourcade D., Atkinson J.P. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4353-4357.
57. Krych-Goldberg M., Atkinson J.P. Structure-function relationships of complement receptor type 1. Immunol. Rev. 2001, 180:112-122.
58. Krych-Goldberg M., Hauhart R.E., Subramanian V.B., Yurcisin B.M., Crimmins D.L., Hourcade D.E., Atkinson J.P. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J. Biol. Chem. 1999, 274:31160-31168.
59. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
60. Levashina E.A., Moita L.F., Blandin S., Vriend G., Lagueux M., Kafatos F.C. Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae. Cell 2001, 104:709-718.
61. Lin E., Tavul L., Michon P., Richards J.S., Dabod E., Beeson J.G., King C.L., Zimmerman P.A., Mueller I. Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in papua new Guinean school children. Am. J. Trop. Med. Hyg. 2010, 83:828-833.
62. Lobo C.-A., Rodriguez M., Reid M., Lustigman S. Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood 2003, 101:4628-4631.
63. Mäck C., Jungermann K., Götze O., Schieferdecker H.L. Anaphylatoxin C5a actions in rat liver: synergistic enhancement by C5a of lipopolysaccharide-dependent alpha(2)-macroglobulin gene expression in hepatocytes via IL-6 release from Kupffer cells. J. Immunol. 2001, 167:3972-3979.
64. Maier A.G., Duraisingh M.T., Reeder J.C., Patel S.S., Kazura J.W., Zimmerman P.A., Cowman A.F. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat. Med. 2003, 9:87-92.
65. Mayer D.C., Kaneko O., Hudson-Taylor D.E., Reid M.E., Miller L.H. Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5222-5227.
66. Mayer D.C.G., Mu J.-B., Feng X., Su X., Miller L.H. Polymorphism in a Plasmodium falciparum erythrocyte-binding ligand changes its receptor specificity. J. Exp. Med. 2002, 196:1523-1528.
67. McNeil L.K., Zagursky R.J., Lin S.L., Murphy E., Zlotnick G.W., Hoiseth S.K., Jansen K.U., Anderson A.S. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol. Mol. Biol. Rev. 2013, 77:234-252.
68. Meri S., Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3982-3986.
69. Meri T., Amdahl H., Lehtinen M.J., Hyvärinen S., McDowell J.V., Bhattacharjee A., Meri S., Marconi R., Goldman A., Jokiranta T.S. Microbes bind complement inhibitor factor H via a common site. PLoS Pathog. 2013, 9:e1003308.
70. Mibei E.K., Orago A.S.S., Stoute J.A. Immune complex levels in children with severe Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2005, 72:593-599.
71. Mitri C., Jacques J.-C., Thiery I., Riehle M.M., Xu J., Bischoff E., Morlais I., Nsango S.E., Vernick K.D., Bourgouin C. Fine pathogen discrimination within the APL1 gene family protects Anopheles gambiae against human and rodent malaria species. PLoS Pathog. 2009, 5:e1000576.
72. Molina-Cruz A., DeJong R.J., Ortega C., Haile A., Abban E., Rodrigues J., Jaramillo-Gutierrez G., Barillas-Mury C. Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E1957-E1962.
73. Molina-Cruz A., Garver L.S., Alabaster A., Bangiolo L., Haile A., Winikor J., Ortega C., van Schaijk B.C.L., Sauerwein R.W., Taylor-Salmon E., et al. The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system. Science 2013, 340:984-987.
74. Moulds J.M. The Knops blood-group system: a review. Immunohematol. Am. Red Cross 2010, 26:2-7.
75. Moulds J.M., Nickells M.W., Moulds J.J., Brown M.C., Atkinson J.P. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J. Exp. Med. 1991, 173:1159-1163.
76. Moulds J.M., Moulds J.J., Brown M., Atkinson J.P. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992, 62:230-235.
77. Moulds J.M., Zimmerman P.A., Doumbo O.K., Kassambara L., Sagara I., Diallo D.A., Atkinson J.P., Krych-Goldberg M., Hauhart R.E., Hourcade D.E., et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001, 97:2879-2885.
78. Moulds J.M., Zimmerman P.A., Doumbo O.K., Diallo D.A., Atkinson J.P., Krych-Goldberg M., Hourcade D.E., Moulds J.J. Expansion of the Knops blood group system and subdivision of Sl(a). Transfusion (Paris) 2002, 42:251-256.
79. Moulds J.M., Pierce S., Peck K.B., Tulley M.L., Doumbo O., Moulds J.J. KAM: a new allele in the Knops blood group system. Transfusion 2005, 45(Suppl. 27A):45.
80. Nagayasu E., Ito M., Akaki M., Nakano Y., Kimura M., Looareesuwan S., Aikawa M. CR1 density polymorphism on erythrocytes of P. falciparum malaria patients in Thailand. Am. J. Trop. Med. Hyg. 2001, 64:1-5.
81. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 1993, 67:6025-6032.
82. Nemerow G.R., Mold C., Schwend V.K., Tollefson V., Cooper N.R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J. Virol. 1987, 61:1416-1420.
83. Noumsi G.T., Tounkara A., Diallo H., Billingsley K., Moulds J.J., Moulds J.M. Knops blood group polymorphism and susceptibility to Mycobacterium tuberculosis infection: knops polymorphism and M. tuberculosis infection. Transfusion (Paris) 2011, 51:2462-2469.
84. Osta M.A., Christophides G.K., Kafatos F.C. Effects of mosquito genes on Plasmodium development. Science 2004, 303:2030-2032.
85. Panda A.K., Panda M., Tripathy R., Pattanaik S.S., Ravindran B., Das B.K. Complement receptor 1 variants confer protection from severe malaria in Odisha, India. PLOS ONE 2012, 7:e49420.
86. Park H.J., Guariento M., Maciejewski M., Hauhart R., Tham W.-H., Cowman A.F., Schmidt C.Q., Mertens H.D.T., Liszewski M.K., Hourcade D.E., et al. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor. J. Biol. Chem. 2014, 289:450-463.
87. Patel S.N., Berghout J., Lovegrove F.E., Ayi K., Conroy A., Serghides L., Min-oo G., Gowda D.C., Sarma J.V., Rittirsch D., et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J. Exp. Med. 2008, 205:1133-1143.
88. Pawluczkowycz A.W., Lindorfer M.A., Waitumbi J.N., Taylor R.P. Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria. J. Immunol. 2007, 179:5543-5552.
89. Payne N.R., Horwitz M.A. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J. Exp. Med. 1987, 166:1377-1389.
90. Ramos T.N., Darley M.M., Hu X., Billker O., Rayner J.C., Ahras M., Wohler J.E., Barnum S.R. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. J. Immunol. 2011, 186:6657-6660.
91. Ramos T.N., Darley M.M., Weckbach S., Stahel P.F., Tomlinson S., Barnum S.R. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. J. Biol. Chem. 2012, 287:24734-24738.
92. Rayner J.C., Galinski M.R., Ingravallo P., Barnwell J.W. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9648-9653.
93. Rayner J.C., Vargas-Serrato E., Huber C.S., Galinski M.R., Barnwell J.W. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J. Exp. Med. 2001, 194:1571-1581.
94. Reiling L., Richards J.S., Fowkes F.J.I., Wilson D.W., Chokejindachai W., Barry A.E., Tham W.-H., Stubbs J., Langer C., Donelson J., et al. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. PLOS ONE 2012, 7:e45253.
95. Reynes M., Aubert J.P., Cohen J.H., Audouin J., Tricottet V., Diebold J., Kazatchkine M.D. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immunol. 1985, 135:2687-2694.
96. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
97. Riedemann N.C., Guo R.-F., Hollmann T.J., Gao H., Neff T.A., Reuben J.S., Speyer C.L., Sarma J.V., Wetsel R.A., Zetoune F.S., et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2004, 18:370-372.
98. Riehle M.M., Markianos K., Niare O., Xu J., Li J., Touré A.M., Podiougou B., Oduol F., Diawara S., Diallo M., et al. Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science 2006, 312:577-579.
99. Riehle M.M., Xu J., Lazzaro B.P., Rottschaefer S.M., Coulibaly B., Sacko M., Niare O., Morlais I., Traore S.F., Vernick K.D. Anopheles gambiae APL1 is a family of variable LRR proteins required for Rel1-mediated protection from the malaria parasite, Plasmodium berghei. PLoS ONE 2008, 3:e3672.
100. Robledo S., Wozencraft A., Valencia A.Z., Saravia N. Human monocyte infection by Leishmania (Viannia) panamensis. Role of complement receptors and correlation of susceptibility in vitro with clinical phenotype. J. Immunol. 1994, 152:1265-1276.
101. Rodriguez de Cordoba S., Lublin D.M., Rubinstein P., Atkinson J.P. Human genes for three complement components that regulate the activation of C3 are tightly linked. J. Exp. Med. 1985, 161:1189-1195.
102. Ross G.D., Lambris J.D., Cain J.A., Newman S.L. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J. Immunol. 1982, 129:2051-2060.
103. Rout R., Dhangadamajhi G., Mohapatra B.N., Kar S.K., Ranjit M. High CR1 level and related polymorphic variants are associated with cerebral malaria in eastern-India. Infect. Genet. Evol. 2011, 11:139-144.
104. Rowe J.A., Moulds J.M., Newbold C.I., Miller L.H. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997, 388:292-295.
105. Rowe J.A., Rogerson S.J., Raza A., Moulds J.M., Kazatchkine M.D., Marsh K., Newbold C.I., Atkinson J.P., Miller L.H. Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J. Immunol. 2000, 165:6341-6346.
106. Rowe J.A., Raza A., Diallo D.A., Baby M., Poudiougo B., Coulibaly D., Cockburn I.A., Middleton J., Lyke K.E., Plowe C.V., et al. Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes Immun. 2002, 3:497-500.
107. Rowe J.A., Handel I.G., Thera M.A., Deans A.-M., Lyke K.E., Koné A., Diallo D.A., Raza A., Kai O., Marsh K., et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17471-17476.
108. Rowe J.A., Opi D.H., Williams T.N. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr. Opin. Hematol. 2009, 16:480-487.
109. Santoro F., Greenstone H.L., Insinga A., Liszewski M.K., Atkinson J.P., Lusso P., Berger E.A. Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem. 2003, 278:25964-25969.
110. Scarselli M., Aricò B., Brunelli B., Savino S., Di Marcello F., Palumbo E., Veggi D., Ciucchi L., Cartocci E., Bottomley M.J., et al. Rational design of a meningococcal antigen inducing broad protective immunity. Sci. Transl. Med. 2011, 3:91ra62.
111. Schaeffer V., Cuschieri J., Garcia I., Knoll M., Billgren J., Jelacic S., Bulger E., Maier R. The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. Shock Augusta Ga 2007, 27:623-630.
112. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 1990, 144:2771-2780.
113. Schmidt C.Q., Herbert A.P., Hocking H.G., Uhrín D., Barlow P.N. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 2008, 151:14-24.
114. Schmidt C.Q., Herbert A.P., Kavanagh D., Gandy C., Fenton C.J., Blaum B.S., Lyon M., Uhrín D., Barlow P.N. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 2008, 181:2610-2619.
115. Schorey J.S., Carroll M.C., Brown E.J. A macrophage invasion mechanism of pathogenic mycobacteria. Science 1997, 277:1091-1093.
116. Da Silva R.P., Hall B.F., Joiner K.A., Sacks D.L. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 1989, 143:617-622.
117. Silver K.L., Higgins S.J., McDonald C.R., Kain K.C. Complement driven innate immune response to malaria: fuelling severe malarial diseases. Cell. Microbiol. 2010, 12:1036-1045.
118. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 1994, 264:1941-1944.
119. Simon N., Lasonder E., Scheuermayer M., Kuehn A., Tews S., Fischer R., Zipfel P.F., Skerka C., Pradel G. Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut. Cell Host Microbe 2013, 13:29-41.
120. Sinha S., Jha G.N., Anand P., Qidwai T., Pati S.S., Mohanty S., Mishra S.K., Tyagi P.K., Sharma S.K., Venkatesh V., et al. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity. Hum. Immunol. 2009, 70:244-250.
121. Skattum L., van Deuren M., van der Poll T., Truedsson L. Complement deficiency states and associated infections. Mol. Immunol. 2011, 48:1643-1655.
122. Spadafora C., Awandare G.A., Kopydlowski K.M., Czege J., Moch J.K., Finberg R.W., Tsokos G.C., Stoute J.A. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog. 2010, 6:e1000968.
123. Stubbs J., Simpson K.M., Triglia T., Plouffe D., Tonkin C.J., Duraisingh M.T., Maier A.G., Winzeler E.A., Cowman A.F. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 2005, 309:1384-1387.
124. Taylor H.M., Triglia T., Thompson J., Sajid M., Fowler R., Wickham M.E., Cowman A.F., Holder A.A. Plasmodium falciparum homologue of the genes for Plasmodium vivax and Plasmodium yoelii adhesive proteins, which is transcribed but not translated. Infect. Immun. 2001, 69:3635-3645.
125. Tedder T.F., Fearon D.T., Gartland G.L., Cooper M.D. Expression of C3b receptors on human be cells and myelomonocytic cells but not natural killer cells. J. Immunol. 1983, 130:1668-1673.
126. Teeranaipong P., Ohashi J., Patarapotikul J., Kimura R., Nuchnoi P., Hananantachai H., Naka I., Putaporntip C., Jongwutiwes S., Tokunaga K. A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria. J. Infect. Dis. 2008, 198:1880-1891.
127. Tetteh-Quarcoo P.B., Schmidt C.Q., Tham W.-H., Hauhart R., Mertens H.D.T., Rowe A., Atkinson J.P., Cowman A.F., Rowe J.A., Barlow P.N. Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria. PLOS ONE 2012, 7:e34820.
128. Tham W.-H., Wilson D.W., Reiling L., Chen L., Beeson J.G., Cowman A.F. Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect. Immun. 2009, 77:2427-2435.
129. Tham W.-H., Wilson D.W., Lopaticki S., Schmidt C.Q., Tetteh-Quarcoo P.B., Barlow P.N., Richard D., Corbin J.E., Beeson J.G., Cowman A.F. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:17327-17332.
130. Tham W.-H., Schmidt C.Q., Hauhart R.E., Guariento M., Tetteh-Quarcoo P.B., Lopaticki S., Atkinson J.P., Barlow P.N., Cowman A.F. Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood 2011, 118:1923-1933.
131. Tham W.-H., Healer J., Cowman A.F. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. Trends Parasitol. 2012, 28:23-30.
132. Thathy V., Moulds J.M., Guyah B., Otieno W., Stoute J.A. Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malar. J. 2005, 4:54.
133. Thiel S., Kolev M., Degn S., Steffensen R., Hansen A.G., Ruseva M., Jensenius J.C. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J. Immunol. 2009, 182:2939-2947.
134. Thomas B.N., Donvito B., Cockburn I., Fandeur T., Rowe J.A., Cohen J.H.M., Moulds J.M. A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa. Genes Immun. 2005, 6:31-36.
135. Thompson J.K., Triglia T., Reed M.B., Cowman A.F. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 2001, 41:47-58.
136. Triglia T., Thompson J.K., Cowman A.F. An EBA175 homologue which is transcribed but not translated in erythrocytic stages of Plasmodium falciparum. Mol. Biochem. Parasitol. 2001, 116:55-63.
137. Veldhuisen B., Ligthart P.C., Vidarsson G., Roels I., Folman C.C., van der Schoot C.E., de Haas M. Molecular analysis of the York antigen of the Knops blood group system. Transfusion (Paris) 2011, 51:1389-1396.
138. Wilson J.G., Murphy E.E., Wong W.W., Klickstein L.B., Weis J.H., Fearon D.T. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 1986, 164:50-59.
139. Xiang L., Rundles J.R., Hamilton D.R., Wilson J.G. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J. Immunol. 1999, 163:4939-4945.
140. Zimmerman P.A., Fitness J., Moulds J.M., McNamara D.T., Kasehagen L.J., Rowe J.A., Hill A.V.S. CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun. 2003, 4:368-373.
141. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740.